These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3061541)

  • 21. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
    Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
    Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relative roles of calcium, phosphorus, and parathyroid hormone in glucose- and tolbutamide-mediated insulin release.
    Harter HR; Santiago JV; Rutherford WE; Slatopolsky E; Klahr S
    J Clin Invest; 1976 Aug; 58(2):359-67. PubMed ID: 956371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pattern of insulin delivery after intravenous glucose injection in man and its relation to plasma glucose disappearance.
    Ferrannini E; Pilo A
    J Clin Invest; 1979 Jul; 64(1):243-54. PubMed ID: 447855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of bombesin on plasma insulin, pancreatic glucagon, and gut glucagon in man.
    Bruzzone R; Tamburrano G; Lala A; Mauceri M; Annibale B; Severi C; de Magistris L; Leonetti F; Delle Fave G
    J Clin Endocrinol Metab; 1983 Apr; 56(4):643-7. PubMed ID: 6339534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basal and stimulated insulin levels: comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects.
    Bagdade JD; Bierman EL; Porte D
    Metabolism; 1971 Nov; 20(11):1000-7. PubMed ID: 5115750
    [No Abstract]   [Full Text] [Related]  

  • 26. Bombesin inhibits growth hormone response to insulin-induced hypoglycemia in humans.
    Scarpignato C; Tirelli F; Pontiroli AE
    Brain Res; 1986 Apr; 371(1):187-9. PubMed ID: 3518864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
    Kadowaki S; Taminato T; Chiba T; Nozawa M; Fujita T; Norman AW
    Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decrease in blood glucose and release of gut glucagon-like immunoreactive materials by bombesin infusion in the dog.
    Matsuyama T; Namba M; Nonaka K; Tarui S; Tanaka R; Shima K
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():115-9. PubMed ID: 7014201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of tolbutamide, glucose, and insulin interrelationships following varying doses of intravenous tolbutamide in normal subjects.
    Ganda OP; Kahn CB; Soeldner JS; Gleason RE
    Diabetes; 1975 Apr; 24(4):354-67. PubMed ID: 1132601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute suppressive effect of human growth hormone on insulin release induced by glucagon and tolbutamide in man.
    Adamson U; Cerasi E
    Diabete Metab; 1975 Mar; 1():51-6. PubMed ID: 1234067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct comparison of standard and insulin modified protocols for minimal model estimation of insulin sensitivity in normal subjects.
    Quon MJ; Cochran C; Taylor SI; Eastman RC
    Diabetes Res; 1994; 25(4):139-49. PubMed ID: 7648784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients.
    Gjesing AP; Hornbak M; Allin KH; Ekstrøm CT; Urhammer SA; Eiberg H; Pedersen O; Hansen T
    Diabetologia; 2014 Jun; 57(6):1173-81. PubMed ID: 24604100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inotropic effects of tolbutamide in man.
    Young JL; Burr IM; Perry JM; Nelson JH; Nies AS
    Am Heart J; 1975 Feb; 89(2):189-94. PubMed ID: 1090133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Theophylline prevents the inhibitory effect of prostaglandin E2 on glucose-induced insulin secretion in man.
    Giugliano D; Cozzolino D; Salvatore T; Giunta R; Torella R
    Acta Endocrinol (Copenh); 1988 Jun; 118(2):187-92. PubMed ID: 2838998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulinotropic action of bombesin-like peptides mediated by gastrin-releasing peptide receptors in steers.
    Zhao HQ; Yao G; Yannaing S; ThanThan S; Kuwayama H
    J Anim Sci; 2016 Jan; 94(1):58-64. PubMed ID: 26812312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.
    D'Alessio DA; Kahn SE; Leusner CR; Ensinck JW
    J Clin Invest; 1994 May; 93(5):2263-6. PubMed ID: 8182159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the action of tolbutamide in normal man. II. Modulation of glucose-induced insulin release by tolbutamide.
    Widström A; Cerasi E
    Acta Endocrinol (Copenh); 1973 Mar; 72(3):519-31. PubMed ID: 4739359
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus.
    Giugliano D; Ceriello A; Saccomanno F; Quatraro A; Paolisso G; D'Onofrio F
    J Clin Endocrinol Metab; 1985 Jul; 61(1):160-6. PubMed ID: 3923028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of short-term lithium carbonate administration on stimulated insulin secretion in normal man.
    Caviezel F; Cattaneo AG; Cetta G; Pozza G
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):188-93. PubMed ID: 3108170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols.
    Saad MF; Steil GM; Kades WW; Ayad MF; Elsewafy WA; Boyadjian R; Jinagouda SD; Bergman RN
    Diabetes; 1997 Jul; 46(7):1167-71. PubMed ID: 9200652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.